• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Standardized controlled antitubercular therapy and results in 755 patients].

作者信息

Wiesner B, Cramer G, Hamel U, Roth G

机构信息

Klinik für Lungenkrankheiten und Tuberkulose, Zentralklinik für Herz- und Lungenkrankheiten Bad Berka.

出版信息

Z Erkr Atmungsorgane. 1991;177(1-2):71-5.

PMID:1808855
Abstract

755 patients were treated because of tuberculosis from 1984-1989. The treatment was standardized according to the recommendations. INH and RMP were used in over 95% as in the hospital as in the ambulatory phase. During the period of 6 yrs. the use of SM was markedly reduced (21.8%) while the use of PZA increased from 14.6% to 55.0%. At least four drugs were used in 22.5%. In 36.2% mycobacteria were found only before starting treatment. After four weeks treatment further 45.1% were negative. Adverse reactions were registered in 9.3%. Concomitant diseases rendering the treatment were observed in 24.7%. Ten patients died because of tuberculosis. Until now only 3 patients had relapses. Controlled treatment is valuable and therefore recommended.

摘要

相似文献

1
[Standardized controlled antitubercular therapy and results in 755 patients].
Z Erkr Atmungsorgane. 1991;177(1-2):71-5.
2
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
3
Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.乌干达东南部艾滋病毒血清阳性和艾滋病毒血清阴性患者的结核病化疗与痰菌转阴情况
East Afr Med J. 1999 Jun;76(6):307-13.
4
Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.尼日利亚伊巴丹肺结核改良短程化疗——初步报告
Afr J Med Med Sci. 2000 Mar;29(1):51-3.
5
The clearance of theophylline is increased during the initial period of tuberculosis treatment.在结核病治疗初期,茶碱的清除率会升高。
Int J Tuberc Lung Dis. 2003 Jun;7(6):587-91.
6
Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.比较两种治疗方案在耐异烟肼肺结核患者中的有效性。
East Mediterr Health J. 2009 Nov-Dec;15(6):1346-50.
7
A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.肺结核6个月化疗对照试验。最终报告:化疗结束后36个月及以后的结果。英国胸科学会
Br J Dis Chest. 1984 Oct;78(4):330-6.
8
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.采用异烟肼、利福平、乙胺丁醇和吡嗪酰胺治疗耐异烟肼结核病6个月。
Int J Tuberc Lung Dis. 2002 Nov;6(11):952-8.
9
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].[使用异烟肼、利福平与吡嗪酰胺固定组合进行肺结核的短期治疗。2年后的结果]
Schweiz Med Wochenschr. 1989 Mar 11;119(10):299-305.
10
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.利福喷汀与异烟肼用于6个月疗程的继续期。5年最终报告:各项指标的预后价值
Int J Tuberc Lung Dis. 2002 Jan;6(1):3-10.